AGAPE ATP CORPORATION Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
AGAPE ATP CORPORATION (ATPC) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $3.01 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2026-08-14
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-06-30 was $3.01K, a 56.71% decline year-over-year.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2026-03-31 was $13.29K, a 4.81% decline year-over-year.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$124.00.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$8.62K.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2025 was -$29.66K.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2024 was -$15.57K.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2023 was -$8.73K, a 141.89% decline from fiscal 2022.
- AGAPE ATP CORPORATION comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was $20.85K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.01K 10-Q · filed 2026-08-14 | $16.30K 10-Q · filed 2026-08-14 | $16.17K derived: sum of 3 quarters · filed 2026-08-14 | $7.55K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $13.29K 10-Q · filed 2026-05-15 | $13.16K derived: sum of 2 quarters · filed 2026-05-15 | $4.54K derived: sum of 3 quarters · filed 2026-05-15 | $11.49K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$124.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$8.74K derived: sum of 2 quarters · filed 2026-04-13 | -$1.79K derived: sum of 3 quarters · filed 2026-08-14 | -$29.66K 10-K · filed 2026-04-13 | ||
| 2025-09-30 | -$8.62K 10-Q · filed 2025-11-13 | -$1.67K derived: sum of 2 quarters · filed 2026-08-14 | -$29.53K 10-Q · filed 2025-11-13 | -$7.51K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $6.95K 10-Q · filed 2026-08-14 | -$6.95K 10-Q · filed 2025-08-13 | $20.91K 10-Q · filed 2026-08-14 | -$20.91K 10-Q · filed 2025-08-13 | $1.11K derived: sum of 3 quarters · filed 2026-08-14 | -$11.42K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $13.96K 10-Q · filed 2026-05-15 | -$13.96K 10-Q · filed 2025-05-15 | -$5.84K derived: sum of 2 quarters · filed 2026-05-15 | -$18.37K derived: sum of 3 quarters · filed 2026-05-15 | -$7.92K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$19.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$32.33K derived: sum of 2 quarters · filed 2026-04-13 | -$21.88K derived: sum of 3 quarters · filed 2026-04-13 | -$15.57K 10-K · filed 2026-04-13 | ||
| 2024-09-30 | -$12.52K 10-Q · filed 2025-11-13 | -$2.08K derived: sum of 2 quarters · filed 2025-11-13 | $4.23K 10-Q · filed 2025-11-13 | $7.08K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $10.44K 10-Q · filed 2025-08-13 | $16.75K 10-Q · filed 2025-08-13 | $19.60K derived: sum of 3 quarters · filed 2025-08-13 | $21.64K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $6.31K 10-Q · filed 2025-05-15 | $9.16K derived: sum of 2 quarters · filed 2025-05-15 | $11.20K derived: sum of 3 quarters · filed 2025-05-15 | $5.79K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $2.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.88K derived: sum of 2 quarters · filed 2025-03-31 | -$516.00 derived: sum of 3 quarters · filed 2025-03-31 | -$8.73K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $2.04K 10-Q · filed 2024-11-14 | -$3.36K derived: sum of 2 quarters · filed 2024-11-14 | -$11.58K 10-Q · filed 2024-11-14 | $9.93K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$5.40K 10-Q · filed 2024-08-14 | -$13.62K 10-Q · filed 2024-08-14 | $7.89K derived: sum of 3 quarters · filed 2024-08-14 | $7.50K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$8.22K 10-Q · filed 2024-05-14 | $13.29K derived: sum of 2 quarters · filed 2024-05-14 | $12.90K derived: sum of 3 quarters · filed 2024-05-14 | $12.63K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $21.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $21.12K derived: sum of 2 quarters · filed 2024-04-01 | $20.85K derived: sum of 3 quarters · filed 2024-04-01 | $20.85K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$387.00 10-Q · filed 2023-11-14 | -$658.00 derived: sum of 2 quarters · filed 2023-11-14 | -$658.00 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$271.00 10-Q · filed 2023-08-14 | -$270.00 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $1.00 10-Q · filed 2023-05-15 | -$1.00 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | -$433.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |